ATTO Attovia Therapeutics, Inc. - Common Stock
No fundamentals data yet for this ticker.
Company insiders 8 insiders · 0 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Colin Walsh | — | Aug. 6, 2026 C | 3,020,632 | 2 | 23 | $8,033,343 |
| venBio Global Strategic Fund IV, L.P. | — | Aug. 6, 2026 C | 4,181,367 | 1 | 0 | $6,499,984 |
| Hubert Chen | — | Aug. 4, 2026 A | — | 0 | 0 | $0 |
| Petter Veiby | — | Aug. 4, 2026 A | — | 0 | 0 | $0 |
| Zaneta Odrowaz | — | Aug. 4, 2026 A | — | 0 | 0 | $0 |
| Attovia Therapeutics, Inc. | — | Aug. 4, 2026 A | — | 0 | 0 | $0 |
| Angie You | — | Aug. 4, 2026 A | — | 0 | 0 | $0 |
| Mitchell Gold | — | Aug. 4, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C. | Aug. 11, 2026 | 13.50% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.